Self-assembling Peptide With Sodium Fluoride in Treating Whi... | Clinical Trial | StuddyBuddy@endsection Self-assembling Peptide With Sodium Fluoride in Treating White Spot Lesionss in Primary Teeth
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05721586

Self-assembling Peptide With Sodium Fluoride in Treating White Spot Lesionss in Primary Teeth

Conditions: White Spot Lesion

Sex: All
Ages: 3 Years – 6 Years
Phase: NA
Enrollment: 24
Sponsor: Hams Hamed Abdelrahman

Location: Egypt

Summary

Regenerative medicine-based approaches for caries treatment focus on biomimetic remineralization of initial carious lesions as a minimally invasive therapy using Self-Assembling Peptide P11-4 (CURODONTTM REPAIR) which enhances remineralization of white spot lesions (WSLs). The study aimed to assess clinically the effect of Self Assembling Peptide P11-4 (CURODONTTM REPAIR) + Fluoride varnish (DURAFLOR) versus a 5% fluoride varnish (DURAFLOR) on remineralization of enamel White Spot Lesions in primary teeth.

Eligibility Criteria

Inclusion Criteria:children with high caries risk with the presence of at least one visible active WSL in primary teeth with ICDAS II score of 1, 2 or 3Exclusion Criteria:Children with systemic diseasesTeeth with cavitated lesion involving dentin and enamel defects

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05721586). StuddyBuddy aggregates publicly available trial information.